Previous Article | Next Article ![]()
J. Virol., 02 1995, 1085-1092, Vol 69, No. 2
W Zauner, D Blaas, E Kuechler and E Wagner
Endocytosis is an efficient method for transfer of genes into mammalian
cells. Incorporation of adenovirus particles into gene transfer complexes
greatly enhances gene delivery, probably by the release of endocytosed DNA
into the cytoplasm. We report here that two different serotypes of human
rhinovirus (HRV), HRV2 and HRV14, are also able to enhance
receptor-mediated gene transfer. The effect of several compounds known to
inhibit viral infection on HRV2- and HRV14-enhanced transfection was
examined. WIN I(s) and WIN IV, two compounds which inhibit viral uncoating,
had different effects on HRV2- and HRV14- enhanced gene transfer to NIH 3T3
cells. While HRV14-enhanced gene transfer was severely reduced in the
presence of these compounds, virtually no effects were observed when HRV2
was used. The use of antiviral compounds thus allowed transfection of human
cells, which are normally lysed rapidly upon infection with HRV. Viral
activity could be mimicked by using a peptide derived from the N terminus
of VP1 of HRV2. This peptide possesses pH-dependent membrane-disrupting
activity and enhances gene transfer to NIH 3T3 and HeLa cells.
Copyright © 1995, American Society for Microbiology
Rhinovirus-mediated endosomal release of transfection complexes
Research Institute of Molecular Pathology, University of Vienna, Austria.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»